<DOC>
	<DOCNO>NCT02525952</DOCNO>
	<brief_summary>The aim study establish selection criterion hepatectomy patient multiple hepatocellular carcinoma base NDR Scoring System</brief_summary>
	<brief_title>Treatment Patients With Multiple Hepatocellular Carcinomas Based NDR Scoring System</brief_title>
	<detailed_description>Multiple hepatocellular carcinoma ( HCCs ) account 60 % 70 % patient hepatocellular carcinoma.However , selection criterion hepatectomy patient multiple HCCs remain controversial.Researches suggest part patient multiple HCCs also benefit hepatectomy.But , expand selection criterion hepatectomy increase tumor recurrence rate reduce therapeutic effect , stringent selection criterion also make part patient take hepatectomy lose operation chance . This difficult problem research field.The Barcelona Clinic Liver Cancer ( BCLC ) system recommend stage A ( number ≤ 3 , large diameter ≤ 3 cm ) suitable liver resection.However , increase report good outcome hepatectomy patient multiple HCCs published.Studies clonal origin suggest hepatectomy well treatment multiple HCCs multicentric origin ( MO ) intrahepatic metastasis ( IM ) 5-year overall survival rate 24 % 58 % .The investigator establish score system ( NDR score ; N , tumor number ; D , total tumor diameter ; R , ratio largest/smallest diameter ) base preoperative data accurately predict postoperative long-term survival patient multiple HCCs.The formula follow : 1×N（N : &gt; 3=1 ; ≤3= 0）+ 2×D（D : &gt; 8cm = 1 ; ≤8cm= 0）+ 1×R（R : &gt; 6 = 1 ; ≤6= 0）.The investigator first propose selection criterion hepatectomy patient multiple HCCs base scoring system . Patients NDR score 0-2 recommend hepatectomy benefit surgery , unsatisfied outcome , patient NDR score 2 recommend hepatectomy.The stringent selection criterion expand patient benefit hepatectomy , less stringent criterion limited ensure curative effect.So , investigator ' NDR score system accurate selecting patient multiple HCCs hepatectomy article publish Ann Surg Oncol（2015，22:826）.In order confirm rationality selection criterion , investigator would like propose prospective randomize control study .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Male female patient &gt; 18 year &lt; =70 year age 2 . Patients preoperatively diagnose hepatocellular carcinoma accord criterion American Association Study Liver Diseases ( AASLD ) . 3 . Preoperative ECOG criterion score 01 4 . ChildPugh class A liver function 5 . Multiple hepatocellular carcinoma tumor number &lt; =5 total tumor diameter &lt; =15 cm 1 . Major portal/hepatic vein invasion 2 . Extrahepatic metastasis 3 . Patients apparent cardiac , pulmonary , cerebral renal dysfunction , may affect treatment liver cancer 4 . Anticancer treatment surgery 5 . Lost followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Carcinoma , Hepatocellular</keyword>
	<keyword>Hepatectomy</keyword>
	<keyword>Transarterial Chemoembolization</keyword>
	<keyword>Scoring System</keyword>
</DOC>